2003 Top 25 Healthcare PR (1)
10 Aug 2005
Mary Cowlett examines how sectoral change hit pharma PR firms in 2002
After a year-long debate, Nick Purdom examines the implications of the EC review on DTC and finds that while reform is necessary, critics contend the proposals are inadequate
Mary Cowlett examines how sectoral change hit pharma PR firms in 2002
PR consultancies capitalised on a remarkable market in a year where acquisitions, a bullish market, high-profile client wins and dot.com boom then bust reigned supreme
Top 150 PR consultancies. For the first time, the Top 150's combined income broke through the £600m mark
There were a few surprises at the top end of the table with acquisitions pushing some of the major networks ahead of rivals who nonetheless showed strong income growth.
PRWeek profiles three agencies that look set for a strong 2005, taken from the financial, consumer and healthcare sectors
The year 2004 was a much more solid one than its predecessor, although agencies still had to work hard to push up their revenues.
Willott Kingston Smith once again presents data filed at Companies House on agencies unable to enter owing to the Sarbanes-Oxley Act